☰

Raveen Parboosing - Publications

Affiliations: 
2013-2017 University of KwaZulu-Natal, Berea, KwaZulu-Natal, South Africa 
Tree Info Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Serumula W, Nkambule B, Parboosing R. Novel Aptamers for the Reactivation of Latent HIV. Current Hiv Research. PMID 37881079 DOI: 10.2174/011570162X248488230926045852  0.425
2023 Francois KA, Msomi N, Govender K, Gounder L, Moodley P, Parboosing R, Chetty I, Xaba L, Khan A. Seroprevalence of SARS-CoV-2 immunoglobulin G in HIV-positive and HIV-negative individuals in KwaZulu-Natal, South Africa. African Journal of Laboratory Medicine. 12: 2065. PMID 37434993 DOI: 10.4102/ajlm.v12i1.2065  0.389
2021 Govender K, Msomi N, Moodley P, Parboosing R. Cytomegalovirus pneumonia of infants in Africa: a narrative literature review. Future Microbiology. PMID 34812046 DOI: 10.2217/fmb-2021-0147  0.361
2021 Chimukangara B, Lessells RJ, Sartorius B, Gounder L, Manyana S, Pillay M, Singh L, Giandhari J, Govender K, Samuel R, Msomi N, Naidoo K, de Oliveira T, Moodley P, Parboosing R. HIV-1 drug resistance in adults and adolescents on protease inhibitor-based antiretroviral treatment in KwaZulu-Natal Province, South Africa. Journal of Global Antimicrobial Resistance. PMID 34785393 DOI: 10.1016/j.jgar.2021.10.023  0.722
2021 Serumula W, Fernandez G, Gonzalez VM, Parboosing R. Anti-HIV aptamers Challenges and Prospects. Current Hiv Research. PMID 34503417 DOI: 10.2174/1570162X19666210908114825  0.465
2017 Singh L, Kruger HG, Maguire GEM, Govender T, Parboosing R. The role of nanotechnology in the treatment of viral infections. Therapeutic Advances in Infectious Disease. 4: 105-131. PMID 28748089 DOI: 10.1177/2049936117713593  0.687
2017 Parboosing R, Chonco L, de la Mata FJ, Govender T, Maguire GE, Kruger HG. Potential inhibition of HIV-1 encapsidation by oligoribonucleotide-dendrimer nanoparticle complexes. International Journal of Nanomedicine. 12: 317-325. PMID 28115849 DOI: 10.2147/Ijn.S114446  0.672
2016 Mdlalose N, Parboosing R, Moodley P. The prevalence of hepatitis B virus infection in HIV-positive and HIV-negative infants: KwaZulu-Natal, South Africa. African Journal of Laboratory Medicine. 5: 283. PMID 28879104 DOI: 10.4102/ajlm.v5i1.283  0.362
2016 Chetty NK, Chonco L, Ijumba NM, Chetty L, Govender T, Parboosing R, Davidson IE. Analysis of Current Pulses in HeLa-Cell Permeabilization Due to High Voltage DC Corona Discharge. Ieee Transactions On Nanobioscience. 15: 526-532. PMID 27824575 DOI: 10.1109/TNB.2016.2585624  0.433
2016 Samuel R, Julian MN, Paredes R, Parboosing R, Moodley P, Singh L, Naidoo A, Gordon M. HIV-1 Drug resistance by Ultra-deep sequencing following short course Zidovudine, single dose Nevirapine and single dose Tenofovir with Emtricitabine for pMTCT. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27327263 DOI: 10.1097/QAI.0000000000001116  0.677
2015 Samuel R, Paredes R, Parboosing R, Moodley P, Singh L, Naidoo A, Gordon M. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission. Journal of Medical Virology. PMID 25940687 DOI: 10.1002/jmv.24220  0.681
2015 Mokaleng BB, Ebenhan T, Ramesh S, Govender T, Kruger HG, Parboosing R, Hazari PP, Mishra AK, Marjanovic-Painter B, Zeevaart JR, Sathekge MM. Synthesis, 68Ga-radiolabeling, and preliminary in vivo assessment of a depsipeptide-derived compound as a potential PET/CT infection imaging agent. Biomed Research International. 2015: 284354. PMID 25699267 DOI: 10.1155/2015/284354  0.565
2015 Somboro AM, Tiwari D, Bester LA, Parboosing R, Chonco L, Kruger HG, Arvidsson PI, Govender T, Naicker T, Essack SY. NOTA: a potent metallo-β-lactamase inhibitor. The Journal of Antimicrobial Chemotherapy. 70: 1594-6. PMID 25567963 DOI: 10.1093/Jac/Dku538  0.672
2014 Samuel R, Paredes R, Parboosing R, Moodley P, Gordon M. Minority HIV-1 drug-resistant mutations and prevention of mother-to-child transmission: perspectives for resource-limited countries. Aids Reviews. 16: 187-98. PMID 25300623  0.355
2013 Singh L, Parboosing R, Manasa J, Moodley P, de Oliveira T. High level of HIV-2 false positivity in KwaZulu-Natal province: a region of South Africa with a very high HIV-1 subtype C prevalence. Journal of Medical Virology. 85: 2065-71. PMID 23959597 DOI: 10.1002/jmv.23716  0.719
2013 Moodley P, Parboosing R, Moodley D. Reduction in perinatal HIV infections in KwaZulu-Natal, South Africa, in the era of more effective prevention of mother to child transmission interventions (2004-2012). Journal of Acquired Immune Deficiency Syndromes (1999). 63: 410-5. PMID 23535294 DOI: 10.1097/QAI.0b013e3182926931  0.328
2012 Gqaleni N, Ngcobo M, Parboosing R, Naidoo A. In vitro testing of African traditional medicines for cytotoxic, immune modulatory and anti-HIV activities. African Journal of Traditional, Complementary, and Alternative Medicines : Ajtcam / African Networks On Ethnomedicines. 9: 2-11. PMID 23983349  0.381
2012 Makatini MM, Petzold K, Arvidsson PI, Honarparvar B, Govender T, Maguire GE, Parboosing R, Sayed Y, Soliman ME, Kruger HG. Synthesis, screening and computational investigation of pentacycloundecane-peptoids as potent CSA-HIV PR inhibitors. European Journal of Medicinal Chemistry. 57: 459-67. PMID 22867528 DOI: 10.1016/J.Ejmech.2012.06.019  0.738
2012 Parboosing R, Maguire GE, Govender P, Kruger HG. Nanotechnology and the treatment of HIV infection. Viruses. 4: 488-520. PMID 22590683 DOI: 10.3390/V4040488  0.622
2012 Pawar SA, Jabgunde AM, Govender P, Maguire GE, Kruger HG, Parboosing R, Soliman ME, Sayed Y, Dhavale DD, Govender T. Synthesis and molecular modelling studies of novel carbapeptide analogs for inhibition of HIV-1 protease. European Journal of Medicinal Chemistry. 53: 13-21. PMID 22542107 DOI: 10.1016/J.Ejmech.2012.03.027  0.748
2011 Makatini MM, Petzold K, Sriharsha SN, Ndlovu N, Soliman ME, Honarparvar B, Parboosing R, Naidoo A, Arvidsson PI, Sayed Y, Govender P, Maguire GE, Kruger HG, Govender T. Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: a hybrid 2D NMR and docking/QM/MM/MD approach. European Journal of Medicinal Chemistry. 46: 3976-85. PMID 21741133 DOI: 10.1016/J.Ejmech.2011.05.071  0.736
2010 Naidoo AF, Parboosing R, Gordon ML. Dual HIV Infection Uncommon in Patients on Antiretroviral Therapy in a Region with High HIV Prevalence. Aids Research and Human Retroviruses. 25: 1225-30. PMID 20001312 DOI: 10.1089/aid.2009.0095  0.36
2008 Parboosing R, Paruk I, Lalloo UG. Hepatitis C virus seropositivity in a South African Cohort of HIV co-infected, ARV naïve patients is associated with renal insufficiency and increased mortality. Journal of Medical Virology. 80: 1530-6. PMID 18649335 DOI: 10.1002/jmv.21262  0.339
Show low-probability matches.